Atlas Trials

An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

Clinical trial NCT05381454 · COMPLETED

Trial details

NCT number
NCT05381454
Sponsor
University of California, Los Angeles
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Respiratory Viral InfectionAntiviral TreatmentCOVID-19
Start date
2022-04-28
Primary completion
2023-05-09
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.